查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2065250

非侵入性血糖監測市場預測至 2034 年：按技術分類的全球分析。

Non-Invasive Glucose Monitoring Market Forecasts to 2034 - Global Analysis By Technology
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球非侵入性血糖監測市場預計將在 2026 年達到 19 億美元，到 2034 年達到 124 億美元，在預測期內複合年成長率為 26.3%。

非侵入性血糖監測是指無需皮膚穿刺、微血管採血或皮下植入感測器即可測量血糖值的技術。這個新興市場包括光學光譜技術（例如近紅外線光譜和拉曼光譜）、經皮感測技術、電磁技術、電阻譜技術以及基於唾液、淚液和呼吸的液體檢測方法。

全球糖尿病盛行率的快速成長，使得舒適便捷的持續血糖監測變得特別重要。

預計到2045年，全球糖尿病患者將超過7.8億，這為非侵入性血糖監測解決方案創造了巨大的市場潛力。傳統的指尖採血和侵入性連續血糖監測系統帶來的疼痛、不便和費用，顯著降低了患者對血糖監測的依從性。非侵入性方法消除了針頭帶來的障礙，使患者能夠更頻繁地進行監測，更好地控制血糖，並減少糖尿病的長期併發症。穿戴式科技的興起以及非糖尿病健康族群對代謝健康的日益關注，進一步擴大了非侵入性血糖監測解決方案的潛在使用者群體，使其不再局限於臨床確診的患者。

極其困難的技術精度挑戰阻礙了監管部門的批准。

對於非侵入性血糖監測的研發者而言，實現與侵入性參考方法相當的臨床可接受的測量精度仍然是一項根本性的科學和工程挑戰。光學和電磁方法中的血糖訊號會受到多種因素的影響，例如皮膚水分含量、溫度、壓力變化、組織異質性以及與頻譜特徵重疊的干擾物質。包括FDA在內的監管機構呼籲進行前瞻性臨床檢驗試驗，以證明其性能能夠滿足ISO 15197精度標準，並適用於不同的患者群體和生理條件。一些資金充足的研發項目未能獲得監管部門的批准，導致投資者持懷疑態度，並延緩了商業化。

將穿戴式技術整合到消費者醫療保健平台中，以實現血糖監測。

將非侵入式血糖感測技術整合到智慧型手錶、健身手環和生物感測器貼片等主流消費性穿戴式平台中，蘊藏著突破性的商業性機會。領先的消費性電子產品製造商正積極開發設備內建血糖監測功能，使血糖數據能夠與心率、血氧飽和度和睡眠指標等數據整合到更全面的健康儀錶板中。穿戴式整合式血糖監測的成功商業化，將大大拓展目標市場，使其不再局限於臨床糖尿病管理，而是覆蓋更廣泛的健康和預防保健消費群體。此外，配套的應用程式生態系統將提供個人化的代謝健康指導和飲食建議。

與先進的、微創的 CGM 系統展開激烈競爭。

微創連續血糖監測系統（CGM）的不斷改進，包括雅培的FreeStyle Libre和德康的G系列平台，意味著非侵入式替代方案必須達到或超過這些性能標準才能獲得臨床應用。這些成熟的系統提供出廠校準的精準度、可連續佩戴數天以及與智慧型手機的無縫整合，這給競爭對手設置了很高的門檻。微創CGM系統擁有大規模的使用者群體、完善的保險報銷機制以及較高的醫生認知度，即使獲得監管部門批准並具備可接受的精準度，這些因素也構成了非侵入式新進入者面臨的巨大成本障礙。

新型冠狀病毒（COVID-19）的影響

新冠疫情凸顯了糖尿病患者易患重症以及在疫情隔離期間難以維持常規血糖監測的困境，從而引發了人們對非侵入性血糖監測的濃厚興趣。醫療機構的有限就醫機會增加了人們對居家監測解決方案的依賴，進一步強化了對更便利、更舒適的血糖測量方法的需求。疫情也加速了對數位健康領域的投資，包括致力於突破性感測技術的非侵入性血糖監測新創公司的資助。疫情後，消費者健康意識的提高和健康監測市場的擴張，推動了非侵入性血糖感測領域的持續投資和商業開發活動。

在預測期內，穿戴式裝置領域預計將佔據最大的市場佔有率。

在非侵入式血糖監測市場中，穿戴式裝置佔據最大的裝置類型佔有率，這反映出消費者對融入日常生活的連續穿戴式健康監測解決方案的偏好。腕帶和貼片式外形規格能夠被動式即時監測血糖值，因此對糖尿病患者和注重健康的消費者都極具吸引力。將血糖感測技術與現有穿戴式健康設備（例如智慧型手錶和健身追蹤器）結合，得益於這些裝置已有的消費群體。

在預測期內，光學光譜技術領域預計將實現最高的複合年成長率。

光學光譜技術，尤其是近紅外線和拉曼光譜技術，預計將在非侵入性血糖監測技術中實現最高的複合年成長率，這主要得益於小型化光子裝置、訊號處理演算法和基於機器學習的校準技術的不斷進步。多家致力於光學光譜技術研發的公司在近期的檢驗研究中展現了其在臨床準確性方面的顯著提升，吸引了來自創業投資和企業的巨額投資。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。北美在非侵入性血糖監測市場佔據最大佔有率，這得益於全球糖尿病技術領域最高的投資集中度、完善的新型血糖監測設備監管體系，以及大規模的糖尿病患者群體及其對創新監測解決方案的接受度。美國的創業投資生態系統為非侵入性血糖監測新創公司提供了大量資金，從而支持其進行長期研究和臨床檢驗計畫。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。受中國擁有全球最多醣尿病患者、印度糖尿病負擔迅速加重以及日本先進的穿戴式技術製造生態系統等因素的推動，亞太地區預計將在無創血糖監測市場實現最高的複合年成長率。在醫療資源有限的情況下，該地區存在大量未滿足的臨床需求，這推動了對價格合理、便利的血糖監測替代方案的強勁需求。在政府主導的醫療數位化計畫和國內醫療設備市場擴張的支持下，各地區的科技公司正積極開發適合亞洲人群的非侵入性血糖監測解決方案。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球非侵入性血糖監測市場：依技術分類

  • 光學光譜學
    • 近紅外線光譜
    • 拉曼光譜
    • 光聲光譜學
    • 光學同調斷層掃描
  • 經皮技術
  • 電磁感
  • 利用螢光監測
  • 電阻光譜
  • 熱輻射技術
  • 基於唾液的血糖監測
  • 利用淚液進行血糖監測
  • 利用呼出氣體進行血糖監測

第6章 全球非侵入性血糖監測市場：依設備類型分類

  • 穿戴式裝置
  • 手持裝置
  • 基於感測器的設備
  • 智慧型手機相容設備

第7章 全球非侵入性血糖監測市場：依產品類型分類

  • 持續血糖監測（CGM）設備
  • 瞬時血糖監測裝置
  • 即時監控系統
  • 綜合糖尿病管理平台

第8章：全球非侵入性血糖監測市場：依通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 直銷
  • 糖尿病專科護理商店

第9章 全球非侵入性血糖監測市場：依應用分類

  • 糖尿病管理
  • 糖尿病前期監測
  • 健身與健康監測
  • 醫院血糖監測
  • 居家醫療監測

第10章：全球無創血糖監測市場：以最終用戶分類

  • 醫院
  • 診所和糖尿病中心
  • 居家醫療
  • 門診手術中心
  • 研究機構
  • 運動和健身用戶
  • 其他最終用戶

第11章 全球無創血糖監測市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Abbott Laboratories
  • Dexcom, Inc.
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd
  • Integrity Applications Inc.
  • Know Labs, Inc.
  • Movano Health
  • Nemaura Medical Inc.
  • GlucoTrack, Inc.
  • Afon Technology Ltd.
  • Cnoga Medical Ltd.
  • PKvitality
  • Biolinq Incorporated
  • DiaMonTech AG
  • Hagar hf.
Product Code: SMRC36765

According to Stratistics MRC, the Global Non-Invasive Glucose Monitoring Market is accounted for $1.9 billion in 2026 and is expected to reach $12.4 billion by 2034, growing at a CAGR of 26.3% during the forecast period. Non-Invasive Glucose Monitoring refers to technologies designed to measure blood glucose levels without requiring skin puncture, capillary blood samples, or subcutaneous sensor insertion. This emerging market spans optical spectroscopy methods including near-infrared and Raman spectroscopy, transdermal sensing, electromagnetic technologies, bioimpedance spectroscopy, and body fluid-based detection approaches utilizing saliva, tears, and exhaled breath.

Market Dynamics:

Driver:

Rapid growth in global diabetes prevalence demanding comfortable, continuous glucose monitoring

The global diabetes epidemic, with projections exceeding 780 million affected individuals by 2045, creates an enormous addressable market for non-invasive glucose monitoring solutions. Patient compliance with blood glucose monitoring is significantly compromised by the pain, inconvenience, and cost associated with traditional fingerstick and invasive continuous glucose monitoring systems. Non-invasive approaches eliminate needle-based barriers, enabling more frequent monitoring, improved glycemic control, and reduced long-term diabetes complications. Wearable technology adoption trends and growing consumer interest in metabolic health among non-diabetic wellness-conscious individuals further expand the potential user base beyond clinically diagnosed patients.

Restraint:

Formidable technical accuracy challenges hindering regulatory clearance

Achieving clinically acceptable measurement accuracy comparable to invasive reference methods remains the fundamental scientific and engineering obstacle for non-invasive glucose monitoring developers. Glucose signals in optical and electromagnetic modalities are confounded by factors including skin hydration, temperature, pressure application variability, tissue heterogeneity, and interfering substances with overlapping spectral signatures. Regulatory agencies including the FDA require prospective clinical validation studies demonstrating performance within the ISO 15197 accuracy standard across diverse patient populations and physiological conditions. Multiple well-funded development programs have failed to achieve regulatory clearance, creating investor skepticism and slowing commercialization.

Opportunity:

Wearable technology convergence enabling glucose monitoring within consumer health platforms

The integration of non-invasive glucose sensing into mainstream consumer wearable platforms, including smartwatches, fitness bands, and biosensor patches, represents a transformative commercial opportunity. Major consumer electronics manufacturers are actively developing on-device glucose monitoring capabilities that would embed glucose data into broader health dashboards alongside heart rate, blood oxygen, and sleep metrics. Successfully commercializing wearable-integrated glucose monitoring would exponentially expand the addressable market beyond clinical diabetes management into the vast wellness and preventive health consumer segment, supported by app ecosystems providing personalized metabolic health coaching and dietary guidance.

Threat:

Intense competition from advanced minimally invasive CGM systems

The continuous improvement of minimally invasive continuous glucose monitoring systems, including Abbott's FreeStyle Libre and Dexcom's G-series platforms, raises the performance benchmark that non-invasive alternatives must match or surpass to achieve clinical adoption. These established systems offer factory-calibrated accuracy, multi-day wear duration, and seamless smartphone integration, creating a high competitive bar. The significant installed user base, established reimbursement frameworks, and strong physician familiarity with minimally invasive CGM systems present substantial switching cost barriers for non-invasive entrants, even after achieving regulatory clearance with acceptable accuracy profiles.

Covid-19 Impact

COVID-19 amplified interest in non-invasive glucose monitoring by highlighting the vulnerability of diabetic patients to severe disease outcomes and the practical difficulties of maintaining blood glucose monitoring routines during pandemic isolation. Reduced access to clinical settings increased reliance on home monitoring solutions, reinforcing demand for easier, more comfortable glucose measurement approaches. The pandemic also accelerated digital health investment, including funding for non-invasive glucose monitoring startups pursuing breakthrough sensing technologies. Post-pandemic, sustained consumer health awareness and growing wellness monitoring market segments continue to attract investment and commercial development activity in non-invasive glucose sensing.

The Wearable Devices segment is expected to be the largest during the forecast period

Wearable devices represent the largest device type segment in the non-invasive glucose monitoring market, reflecting consumer preference for continuous, on-body health monitoring solutions integrated into everyday routines. Wristband and patch form factors that enable passive, real-time glucose trend monitoring are particularly attractive for both diabetic and wellness-focused user segments. The convergence of glucose sensing with established wearable health device categories including smartwatches and fitness trackers benefits from existing consumer adoption infrastructure.

The Optical Spectroscopy Technology segment is expected to have the highest CAGR during the forecast period

Optical spectroscopy, particularly near-infrared and Raman spectroscopy approaches, is expected to register the highest CAGR among non-invasive glucose monitoring technologies, driven by ongoing advances in miniaturized photonic components, signal processing algorithms, and machine learning-based calibration techniques. Multiple companies pursuing optical spectroscopy pathways have demonstrated encouraging clinical accuracy improvements in recent validation studies, attracting significant venture capital and corporate investment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, North America holds the largest share of the non-invasive glucose monitoring market, supported by the highest global concentration of diabetes technology investment, established regulatory pathways for novel glucose monitoring devices, and a substantial diabetic patient population with demonstrated willingness to adopt innovative monitoring solutions. The United States venture capital ecosystem has provided extensive funding to non-invasive glucose monitoring startups, enabling prolonged research and clinical validation programs.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Asia Pacific is projected to achieve the highest CAGR in the non-invasive glucose monitoring market, driven by China's position as the world's largest diabetic population, India's rapidly growing diabetes burden, and Japan's advanced wearable technology manufacturing ecosystem. Significant unmet clinical need in markets with limited healthcare access is driving strong demand for affordable, convenient glucose monitoring alternatives. Regional technology companies are actively developing non-invasive glucose solutions tailored to Asian populations, supported by government health digitization programs and expanding domestic medical device.

Key players in the market

Some of the key players in Global Non-Invasive Glucose Monitoring Market include Abbott Laboratories, Dexcom Inc., Medtronic plc, F. Hoffmann-La Roche Ltd, Integrity Applications Inc., Know Labs Inc., Movano Health, Nemaura Medical Inc., GlucoTrack Inc., Afon Technology Ltd., Cnoga Medical Ltd., PKvitality, Biolinq Incorporated, DiaMonTech AG, and Hagar hf.

Key Developments:

In March 2026, Know Labs reported positive interim results from an expanded clinical accuracy validation study of its radio frequency-based non-invasive glucose monitoring technology, demonstrating performance approaching ISO 15197 standard thresholds across a diverse patient cohort, advancing the company's regulatory submission timeline toward an anticipated FDA de novo authorization pathway.

In January 2026, Movano Health announced the initiation of a pivotal clinical study for its wearable ring-based non-invasive glucose monitoring platform, enrolling participants across multiple clinical sites to generate the prospective real-world accuracy data required to support a formal FDA premarket submission for its biosensor technology.

Technologies Covered:

  • Optical Spectroscopy
  • Transdermal Technology
  • Electromagnetic Sensing
  • Fluorescence-based Monitoring
  • Bioimpedance Spectroscopy
  • Thermal Emission
  • Saliva/Tear/Breath-based

Device Types Covered:

  • Wearable Devices
  • Handheld Devices
  • Sensor-based Devices
  • Smartphone-integrated Devices

Product Types Covered:

  • CGM Devices
  • Flash Glucose Monitoring
  • Real-time Monitoring Systems
  • Integrated Diabetes Management Platforms

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Direct Sales
  • Specialty Diabetes Care Stores

Applications Covered:

  • Diabetes Management
  • Prediabetes Monitoring
  • Fitness & Wellness Monitoring
  • Hospital Glucose Monitoring
  • Home Healthcare Monitoring

End Users Covered:

  • Hospitals
  • Clinics & Diabetes Centers
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Research Institutes
  • Sports & Fitness Users
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Non-Invasive Glucose Monitoring Market, By Technology

  • 5.1 Optical Spectroscopy
    • 5.1.1 Near-Infrared Spectroscopy
    • 5.1.2 Raman Spectroscopy
    • 5.1.3 Photoacoustic Spectroscopy
    • 5.1.4 Optical Coherence Tomography
  • 5.2 Transdermal Technology
  • 5.3 Electromagnetic Sensing
  • 5.4 Fluorescence-based Monitoring
  • 5.5 Bioimpedance Spectroscopy
  • 5.6 Thermal Emission Technology
  • 5.7 Saliva-based Glucose Monitoring
  • 5.8 Tear-based Glucose Monitoring
  • 5.9 Breath-based Glucose Monitoring

6 Global Non-Invasive Glucose Monitoring Market, By Device Type

  • 6.1 Wearable Devices
  • 6.2 Handheld Devices
  • 6.3 Sensor-based Devices
  • 6.4 Smartphone-integrated Devices

7 Global Non-Invasive Glucose Monitoring Market, By Product Type

  • 7.1 Continuous Glucose Monitoring (CGM) Devices
  • 7.2 Flash Glucose Monitoring Devices
  • 7.3 Real-time Monitoring Systems
  • 7.4 Integrated Diabetes Management Platforms

8 Global Non-Invasive Glucose Monitoring Market, By Distribution Channel

  • 8.1 Hospital Pharmacies
  • 8.2 Retail Pharmacies
  • 8.3 Online Pharmacies
  • 8.4 Direct Sales
  • 8.5 Specialty Diabetes Care Stores

9 Global Non-Invasive Glucose Monitoring Market, By Application

  • 9.1 Diabetes Management
  • 9.2 Prediabetes Monitoring
  • 9.3 Fitness & Wellness Monitoring
  • 9.4 Hospital Glucose Monitoring
  • 9.5 Home Healthcare Monitoring

10 Global Non-Invasive Glucose Monitoring Market, By End User

  • 10.1 Hospitals
  • 10.2 Clinics & Diabetes Centers
  • 10.3 Home Care Settings
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Research Institutes
  • 10.6 Sports & Fitness Users
  • 10.7 Other End Users

11 Global Non-Invasive Glucose Monitoring Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Abbott Laboratories
  • 14.2 Dexcom, Inc.
  • 14.3 Medtronic plc
  • 14.4 F. Hoffmann-La Roche Ltd
  • 14.5 Integrity Applications Inc.
  • 14.6 Know Labs, Inc.
  • 14.7 Movano Health
  • 14.8 Nemaura Medical Inc.
  • 14.9 GlucoTrack, Inc.
  • 14.10 Afon Technology Ltd.
  • 14.11 Cnoga Medical Ltd.
  • 14.12 PKvitality
  • 14.13 Biolinq Incorporated
  • 14.14 DiaMonTech AG
  • 14.15 Hagar hf.

List of Tables

  • Table 1 Global Non-Invasive Glucose Monitoring Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Non-Invasive Glucose Monitoring Market Outlook, By Technology (2023-2034) ($MN)
  • Table 3 Global Non-Invasive Glucose Monitoring Market Outlook, By Optical Spectroscopy (2023-2034) ($MN)
  • Table 4 Global Non-Invasive Glucose Monitoring Market Outlook, By Near-Infrared Spectroscopy (2023-2034) ($MN)
  • Table 5 Global Non-Invasive Glucose Monitoring Market Outlook, By Raman Spectroscopy (2023-2034) ($MN)
  • Table 6 Global Non-Invasive Glucose Monitoring Market Outlook, By Photoacoustic Spectroscopy (2023-2034) ($MN)
  • Table 7 Global Non-Invasive Glucose Monitoring Market Outlook, By Optical Coherence Tomography (2023-2034) ($MN)
  • Table 8 Global Non-Invasive Glucose Monitoring Market Outlook, By Transdermal Technology (2023-2034) ($MN)
  • Table 9 Global Non-Invasive Glucose Monitoring Market Outlook, By Electromagnetic Sensing (2023-2034) ($MN)
  • Table 10 Global Non-Invasive Glucose Monitoring Market Outlook, By Fluorescence-based Monitoring (2023-2034) ($MN)
  • Table 11 Global Non-Invasive Glucose Monitoring Market Outlook, By Bioimpedance Spectroscopy (2023-2034) ($MN)
  • Table 12 Global Non-Invasive Glucose Monitoring Market Outlook, By Thermal Emission Technology (2023-2034) ($MN)
  • Table 13 Global Non-Invasive Glucose Monitoring Market Outlook, By Saliva-based Glucose Monitoring (2023-2034) ($MN)
  • Table 14 Global Non-Invasive Glucose Monitoring Market Outlook, By Tear-based Glucose Monitoring (2023-2034) ($MN)
  • Table 15 Global Non-Invasive Glucose Monitoring Market Outlook, By Breath-based Glucose Monitoring (2023-2034) ($MN)
  • Table 16 Global Non-Invasive Glucose Monitoring Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 17 Global Non-Invasive Glucose Monitoring Market Outlook, By Wearable Devices (2023-2034) ($MN)
  • Table 18 Global Non-Invasive Glucose Monitoring Market Outlook, By Handheld Devices (2023-2034) ($MN)
  • Table 19 Global Non-Invasive Glucose Monitoring Market Outlook, By Sensor-based Devices (2023-2034) ($MN)
  • Table 20 Global Non-Invasive Glucose Monitoring Market Outlook, By Smartphone-integrated Devices (2023-2034) ($MN)
  • Table 21 Global Non-Invasive Glucose Monitoring Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 22 Global Non-Invasive Glucose Monitoring Market Outlook, By Continuous Glucose Monitoring (CGM) Devices (2023-2034) ($MN)
  • Table 23 Global Non-Invasive Glucose Monitoring Market Outlook, By Flash Glucose Monitoring Devices (2023-2034) ($MN)
  • Table 24 Global Non-Invasive Glucose Monitoring Market Outlook, By Real-time Monitoring Systems (2023-2034) ($MN)
  • Table 25 Global Non-Invasive Glucose Monitoring Market Outlook, By Integrated Diabetes Management Platforms (2023-2034) ($MN)
  • Table 26 Global Non-Invasive Glucose Monitoring Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 27 Global Non-Invasive Glucose Monitoring Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 28 Global Non-Invasive Glucose Monitoring Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 29 Global Non-Invasive Glucose Monitoring Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 30 Global Non-Invasive Glucose Monitoring Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 31 Global Non-Invasive Glucose Monitoring Market Outlook, By Specialty Diabetes Care Stores (2023-2034) ($MN)
  • Table 32 Global Non-Invasive Glucose Monitoring Market Outlook, By Application (2023-2034) ($MN)
  • Table 33 Global Non-Invasive Glucose Monitoring Market Outlook, By Diabetes Management (2023-2034) ($MN)
  • Table 34 Global Non-Invasive Glucose Monitoring Market Outlook, By Prediabetes Monitoring (2023-2034) ($MN)
  • Table 35 Global Non-Invasive Glucose Monitoring Market Outlook, By Fitness & Wellness Monitoring (2023-2034) ($MN)
  • Table 36 Global Non-Invasive Glucose Monitoring Market Outlook, By Hospital Glucose Monitoring (2023-2034) ($MN)
  • Table 37 Global Non-Invasive Glucose Monitoring Market Outlook, By Home Healthcare Monitoring (2023-2034) ($MN)
  • Table 38 Global Non-Invasive Glucose Monitoring Market Outlook, By End User (2023-2034) ($MN)
  • Table 39 Global Non-Invasive Glucose Monitoring Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 40 Global Non-Invasive Glucose Monitoring Market Outlook, By Clinics & Diabetes Centers (2023-2034) ($MN)
  • Table 41 Global Non-Invasive Glucose Monitoring Market Outlook, By Home Care Settings (2023-2034) ($MN)
  • Table 42 Global Non-Invasive Glucose Monitoring Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 43 Global Non-Invasive Glucose Monitoring Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 44 Global Non-Invasive Glucose Monitoring Market Outlook, By Sports & Fitness Users (2023-2034) ($MN)
  • Table 45 Global Non-Invasive Glucose Monitoring Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.